Status message

Active context: kki_bg_colors_yellow

A Retrospecitve Evaluation of Bisphosphonate Treatment on Bone Mineral Density and Fracture Incidence in Cerebral Palsy and Spina Bifida Patients

Principal Investigator:

Children with cerebral palsy and spina bifida, many of whom are non ambulatory, have bone mineral density in the osteopenic/osteoporotic range. These children have an increased risk of fracture. These children have been treated with bisphosphonate. The purpose of this study is review data in the patient's medical record related to their response or lack of response to bisphosphonate treatment.

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.
Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.